TB Online is no longer maintained. This is an archive of the site. For news on TB please go to:
https://globaltbcab.org/Rifampicin may be safer than isoniazid in latent TB treatment
Zahra Masoud
Feb. 10, 2020, 9:16 p.m.
In patients without a contraindication, rifampicin may be the safest treatment option for latent tuberculosis (TB) infection, according to results of a study published in the Lancet Infectious Diseases.